The Patient‐Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis

Author:

Foong Yi Chao1234ORCID,Merlo Daniel13,Gresle Melissa125,Zhu Chao1,Buzzard Katherine35,Lechner‐Scott Jeannette67,Barnett Michael89,Taylor Bruce10,Kalincik Tomas1112ORCID,Kilpatrick Trevor1213,Darby David123,Dobay Pamela14,van Beek Johan14,Hyde Robert14,Butzkueven Helmut12,van der Walt Anneke12

Affiliation:

1. Department of Neuroscience Central Clinical School, Monash University Melbourne Victoria Australia

2. Alfred Health Melbourne Victoria Australia

3. Eastern Health Melbourne Victoria Australia

4. Royal Hobart Hospital Hobart Tasmania Australia

5. Melbourne Health Melbourne Victoria Australia

6. The University of Newcastle Newcastle New South Wales Australia

7. Hunter New England Health Newcastle New South Wales Australia

8. Brain and Mind Centre The University of Sydney Sydney New South Wales Australia

9. Sydney Neuroimaging Analysis Centre Camperdown New South Wales Australia

10. Menzies Institute for Medical Research University of Tasmania Hobart Tasmania Australia

11. Department of Medicine, CORe University of Melbourne Melbourne Victoria Australia

12. Department of Neurology Neuroimmunology Centre, Royal Melbourne Hospital Melbourne Victoria Australia

13. Florey Department of Neuroscience and Mental Health University of Melbourne Melbourne Victoria Australia

14. Biogen International GmbH Zug Switzerland

Abstract

AbstractBackground and purposeThe validity, reliability, and longitudinal performance of the Patient‐Determined Disease Steps (PDDS) scale is unknown in people with multiple sclerosis (MS) with mild to moderate disability. We aimed to examine the psychometric properties and longitudinal performance of the PDDS.MethodsWe included relapsing–remitting MS patients with an Expanded Disability Status Scale (EDSS) score of less than 4. Validity and test–retest reliability was examined. Longitudinal data were analysed with mixed‐effect modelling and Cohen's kappa for concordance in confirmed disability progression (CDP).ResultsWe recruited a total of 1093 participants, of whom 904 had complete baseline data. The baseline correlation between PDDS and EDSS was weak (ρ = 0.45, p < 0.001). PDDS had stronger correlations with patient‐reported outcomes (PROs). Conversely, EDSS had stronger correlations with age, disease duration, Kurtzke's functional systems and processing speed test. PDDS test–retest reliability was good to excellent (concordance correlation coefficient = 0.73–0.89). Longitudinally, PDDS was associated with EDSS, age and depression. A higher EDSS score was associated with greater PDSS progression. The magnitude of these associations was small. There was no concordance in CDP as assessed by PDDS and EDSS.ConclusionThe PDDS has greater correlation with other PROs but less correlation with other MS‐related outcome measures compared to the EDSS. There was little correlation between PDDS and EDSS longitudinally. Our findings suggest that the PDDS scale is not interchangeable with the EDSS.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3